Evaluating the efficacy of probiotics in schizophrenia and depression: A meta-analysis of clinical outcomes and subgroup effects
Published online on November 19, 2025
Abstract
Nutrition and Health, Ahead of Print.
BackgroundSchizophrenia and depression are disabling mental disease conditions that have multifactorial pathophysiology involving the dysregulation of the gut–brain axis. Probiotics have been advocated as an adjunct therapy that could have an impact on ...
BackgroundSchizophrenia and depression are disabling mental disease conditions that have multifactorial pathophysiology involving the dysregulation of the gut–brain axis. Probiotics have been advocated as an adjunct therapy that could have an impact on ...